Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Molecular Cancer Research : MCR|January 17, 2009
Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?Mark Wade, Geoffrey M WahlThe International Journal of Biochemistry & Cell Biology|May 15, 2007
MDM2 and MDM4: p53 regulators as targets in anticancer therapyFranck Toledo, Geoffrey M WahlNature Reviews. Cancer|November 28, 2006
Regulating the p53 pathway: in vitro hypotheses, in vivo veritasFranck Toledo, Geoffrey M WahlAnnual Review of Pathology|October 13, 2023
Cancer as a Disease of Development Gone AwryBen Z Stanger, Geoffrey M WahlCell Cycle (Georgetown, Tex.)|February 3, 2005
A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activationJayne M Stommel, Geoffrey M WahlGenes & Cancer|July 23, 2011
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the GenomeBenjamin T Spike, Geoffrey M WahlCancer Cell|May 26, 2012
What a difference a phosphate makes: life or death decided by a single amino acid in MDM2Yao-Cheng Li, Geoffrey M WahlNPJ Breast Cancer|June 27, 2017
Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneityGeoffrey M Wahl, Benjamin T SpikeThe EMBO Journal|March 19, 2004
Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activationJayne M Stommel, Geoffrey M WahlNature Reviews. Cancer|January 11, 2013
MDM2, MDMX and p53 in oncogenesis and cancer therapyMark Wade, Yao-Cheng Li, Geoffrey M WahlPageof 8